ORMP icon

Oramed Pharmaceuticals

77 hedge funds and large institutions have $43.2M invested in Oramed Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34M
Puts
$3.72M
Net Calls
Net Calls Change

Top Buyers

1 +$4.61M
2 +$1.44M
3 +$1.09M
4
Group One Trading
Group One Trading
Illinois
+$757K
5
XT
XTX Topco
Cayman Islands
+$687K

Top Sellers

1 -$2.53M
2 -$1.12M
3 -$1.06M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$958K
5
EMG
ETF Managers Group
New Jersey
-$612K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.9M
2
$4.87M
3
$4.61M
4
$3.81M
5
$3.03M
6
$2.23M
7
$1.6M
8
$1.27M
9
$1.23M
10
$793K
11
$778K
12
$687K
13
$680K
14
$675K
15
$665K
16
$645K
17
$613K
18
$554K
19
$515K
20
$478K
21
$462K
22
$453K
23
$450K
24
$390K
25
$360K